Acecainide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C15H23N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 910Q707V6F, chemically known as benzamide, 4-(acetylamino)-n-(2-(diethylamino)ethyl)- but more generally known as acecainide, which bears US NIH Compound Identifier 4342. Acecainide most often appears in forms base and hydrochloride. European Medicines Agency schedules Acecainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07372MIG. The term ACECAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). ACECAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule acecainide under HS 29242995 and SITC 51479. As of Q4 2014, ACECAINIDE remains US FDA's Preferred Term for this commodity. Acecainide bears US NLM identifiers UMLS ID C0001061 and NCI Concept Code C75125. SMILES: O=C(NCCN(CC)CC)C1CCC(NC(=O)C)CC1.